The Mang-gom Effect: Character IP, AOV & Retail Acceleration

APR’s $1B Pivot: From Skincare to Medical Devices

APR has crossed ₩1.5 trillion KRW (over $1B USD) in revenue — and is now expanding beyond skincare into professional-grade medical devices. In this episode of Crying in O.Y., we break down why Medicube’s parent company is moving up the value chain, shifting from mass cosmetics into energy-based clinical equipment. We cover: • How APR doubled revenue year-over-year • Why cosmetics margins eventually compress • The economics of higher ASP through devices • The clinic → home maintenance “treatment loop” • The role of PDRN and longevity positioning • What regulatory approval and hospital adoption will determine next This isn’t product expansion. It’s margin expansion and category repositioning. For professionals in beauty retail, brand strategy, distribution, and aesthetics.

The $25B Live Commerce Shift: How Korea Moved Beyond TV Home Shopping

South Korea’s retail landscape is undergoing a massive shift. In this episode, Zac explores the decline of traditional TV home shopping and the explosive growth of Live Commerce. We discuss the "Big Seven" networks, the crushing weight of transmission fees, and how platforms like Naver and Coupang are using "Rocket Delivery" and social engagement to capture the MZ generation. Plus, a look at how Live Commerce bridges the "Spatial Gap" for regional consumers and what the future holds for AI virtual hosts in the beauty space. Follow the pod on IG: @cryingino.yLanguage & Global Insights: @goojeon.insight

The Mang-gom Effect: Character IP, AOV & Retail Acceleration

Sorry for the late post—moving house is a full-time job! 📦 In today's episode, your host Zac explores the fascinating world of character collaborations in South Korea. We’re moving beyond the surface-level "cuteness" to look at the hard data: Why do characters like MangGOM drive a 300%–400% increase in web traffic? We analyze the shift from children’s TV icons to "Kidult" culture and how brands like Beplain, Anua, and Numbuzin are using limited-edition merch to clear a quarter’s worth of inventory in just weeks. Key Highlights: * The business of "healing" through IP. * Analysis of Olive Young’s ever-changing Best Seller list. * How character branding helps K-beauty penetrate the US and SE Asian markets. Stay Connected:IG: @cryinginoliveyoungK-Beauty Language Insights: @goojeon.insight

CJ Olive Young’s $20B Wellness Pivot: Inside Olive Better

In this briefing, we dissect the emergence of K-Wellness via the launch of Olive Young's newest platform, Olive Better. We analyze the 2026 F.U.L.L.M.O.O.N. framework and why the industry is pivoting toward "Wholeness" and "Healthy Pleasure." Professional Takeaways: * Beyond Cosmetics: The strategic re-branding of "Health" to "Wellness" as a daily lifestyle practice. * Longevity Economy: How the Gwanghwamun flagship targets high-stress corporate demographics. * The Ingestible Wave: Data supporting the 140-fold increase in inner-beauty film and functional snack consumption. Industry Network: * Visuals: Follow @cryinginoliveyoung on Instagram for updates and more * Global Market News: For insights into how K-Beauty globally, subscribe to @GooJeon—the definitive source for K-Beauty’s international market impact.

Torriden at 100B Won: LG H&H Signals & Indie Consolidation

Host Zac returns to the "Crying in Olive Young" studio to dissect the success of Torriden, a brand that has mastered the middle ground between "Clean Beauty" and "Dermacosmetics." With the Dive-In Low Molecular Hyaluronic Acid Serum reaching 11 million units sold as of 2025, Torriden isn't just a trend—it's a category leader. We explore the "5-D Complex" technology that makes their HA serum a global bestseller at Sephora and Boots, and why it consistently tops the Olive Young charts. The Business Sidebar: We address the rumors surrounding LG Household & Health Care (LG H&H) and their interest in the indie market. What does CEO Lee Sun-Joo’s "Agile Adaptation" strategy mean for the future of K-Beauty? Plus, we provide an essential update on Dr. Althea’s recent press release regarding their 2026 expansion and internal sale discussions. Key Highlights: * Torriden’s "Your Skin is Our Planet" ethos. * The math behind a 100-billion-won brand. * Hyaluronic Acid: Molecular weights explained. * LG H&H’s shift away from legacy brands toward indie prospects. * Dr. Althea’s 2026 recruitment and growth update. Connect with us:IG: @CryingInOliveYoungKorean Language K-Beauty Updates: @Goojeon